Publications by authors named "Vijay Modur"

Claim this Profile
P
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients.
Vivek Subbiah, Peter P Yu, Rangaprasad Sarangarajan, Michael A Kiebish, Leonardo O Rodrigues, Vijay Modur

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry Disease.
Dominique P Germain, Pronabesh DasMahapatra, Shiguang Liu, Patrick Deegan, Alberto Ortiz, Vijay Modur

Mol Genet Genomic Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer.
Esteban Terzo, Shruti A Apte, Simran Padhye, Saleh Rashed, Wesley Austin, Vijay Modur

Cancer Res Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Ronald T Gansevoort, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B Chapman, Vijay Modur

Am J Kidney Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel read through agent: ZKN-0013 demonstrates efficacy in APC model of familial adenomatous polyposis.
Martin R Graf, Shruti Apte, Esteban Terzo, Simran Padhye, Shuhao Shi, Vijay Modur

J Mol Med (Berl)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study.
Patrick B Deegan, Ozlem Goker-Alpan, Tarekegn Geberhiwot, Robert J Hopkin, Elena Lukina, Vijay Modur

Mol Genet Metab· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD.
Ronald D Perrone, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B Chapman, Vijay Modur

Kidney Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease.
Alaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, Chad Gwaltney, Charlie Iaconangelo, Vijay Modur

Mol Genet Metab Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of cilia structure and function alleviates multi-organ pathology in Bardet-Biedl syndrome mice.
Hervé Husson, Nikolay O Bukanov, Sarah Moreno, Mandy M Smith, Brenda Richards, Vijay Modur

Hum Mol Genet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosphingolipid metabolism and polycystic kidney disease.
Thomas A Natoli, Vijay Modur, Oxana Ibraghimov-Beskrovnaya

Cell Signal· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.
Ronald C Hendrickson, Anita Y H Lee, Qinghua Song, Andy Liaw, Matt Wiener, Vijay Modur

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in Pharmaceutical Research.
Xuemei Zhao, Vijay Modur, Leonidas N Carayannopoulos, Omar F Laterza

Clin Chem· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Jeffrey L Seeburger, Daniel J Holder, Marc Combrinck, Catharine Joachim, Omar Laterza, Vijay Modur

J Alzheimers Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
Helen E White, John Hedges, Israel Bendit, Susan Branford, Dolors Colomer, Vijay Modur

Clin Chem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based laboratory medicine in oncology drug development: from biomarkers to diagnostics.
Vijay Modur, Eric Hailman, J C Barrett

Clin Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are companion diagnostics useful?
J Carl Barrett, Melanie M Frigault, Simon Hollingsworth, Glenn A Miller, Vijay Modur

Clin Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.
Andrew M Stein, Dean Bottino, Vijay Modur, Susan Branford, Jaspal Kaeda

Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS).
Timothy P Hughes, Andreas Hochhaus, Susan Branford, Martin C Müller, Jaspal S Kaeda, Vijay Modur

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.
Jin-Moo Lee, Kaj Blennow, Niels Andreasen, Omar Laterza, Vijay Modur

Clin Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of tissue injury.
Omar F Laterza, Vijay R Modur, Jack H Ladenson

Biomark Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel brain biomarkers.
Omar F Laterza, Vijay R Modur, Dan L Crimmins, Jitka V Olander, Yvonne Landt

Clin Chem· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrichment of genes in the aortic intima that are associated with stratified epithelium: implications of underlying biomechanical and barrier properties of the arterial intima.
Pampee P Young, Vijay Modur, Amylynn A Teleron, Jack H Ladenson

Circulation· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis